STOCK TITAN

Cloud Dx Stock Price, News & Analysis

CDXFF OTC

Welcome to our dedicated page for Cloud Dx news (Ticker: CDXFF), a resource for investors and traders seeking the latest updates and insights on Cloud Dx stock.

The CDXFF news page on Stock Titan provides an organized archive of public announcements and developments related to Cloud DX Inc., a former North American digital health platform and provider of virtual care and remote patient monitoring solutions. These news releases document how the company positioned its Connected Health remote patient monitoring platform, which was used by healthcare enterprises and care teams across North America to manage chronic disease, support aging in place, and deliver hospital-quality post-surgical care in the home.

Through these historical updates, readers can review Cloud DX’s disclosures about contracts with hospitals, community paramedic services, clinics, and provincial or territorial health authorities, as well as its reported role in providing remote patient monitoring products and services. The archive also includes company statements about awards and recognition, such as being the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist, and one of "Canada's Ten Most Prominent Telehealth Providers."

In addition to growth and contract announcements, the CDXFF news record covers Cloud DX’s restructuring process. Key items include the filing of a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act (Canada) by its material subsidiary, the court-supervised sale of Cloud Diagnostics Canada ULC under a reverse vesting order, and the company’s later disclosure that it ceased operations and transferred all assets to a purchaser. The news flow also documents the Cease Trade Order issued by the Ontario Securities Commission due to the company’s inability to file audited financial statements for its 2024 fiscal year.

By browsing this page, investors and researchers can follow the full narrative arc of Cloud DX Inc. (CDXFF) through its contract wins, financial reporting announcements, restructuring steps, and eventual cessation of operations, using the company’s own news releases as a primary source.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Cloud DX, a healthcare technology company specializing in automated remote patient monitoring (RPM) and artificial intelligence, is set to present at the Planet MicroCap Showcase: VEGAS 2023 on April 26, 2023, at 8:30 AM PDT. Founder and CEO Robert Kaul will deliver a presentation and conduct one-on-one investor meetings on April 27.

In 2023, Cloud DX has achieved a remarkable increase in business, signing 15 new agreements for RPM solutions, surpassing the total of 28 contracts from 2022. Contract values range from approximately $75,000 CAD to over $1,000,000 CAD. The company recently unveiled its 11th and 12th patents, enhancing its status as a leader in digital health.

Remote patient monitoring is gaining traction, with US healthcare payers offering full reimbursement, thus making these services more accessible. Cloud DX is a preferred RPM provider in Canada, serving major hospital systems and government entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Cloud DX (TSXV:CDX)(OTC:CDXFF) has announced three new contracts in 2023, bringing the total to 15 agreements this year, significantly up from 28 in 2022. The new contracts include a primary care practice in Illinois adopting the Connected Health™ platform and two extensions from Canadian health providers for their remote patient monitoring programs. The Illinois clinic expects to generate up to $170,000 CAD in the first year, while the extensions could provide up to $90,000 CAD collectively. The company continues to experience growth in demand for virtual care technologies, which enhance healthcare delivery and patient satisfaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.64%
Tags
none
Rhea-AI Summary

Cloud DX (TSXV:CDX)(OTC:CDXFF) reports significant progress in Q1 2023, securing 12 contracts, marking a 150% year-over-year increase in contract extensions. The Connected Health™ platform shows a 3X growth among existing clients, reflecting a permanent shift in healthcare delivery. Total contract values are projected up to $800,000 CAD in the first year, primarily from hardware purchases and subscription services. Cloud DX aims to enhance remote patient monitoring through better healthcare outcomes and reduced hospitalizations, with patient satisfaction exceeding 97%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cloud DX has secured a three-year contract with an Ontario healthcare organization to provide Remote Patient Monitoring (RPM) for Congestive Heart Failure (CHF) patients, replacing the current telehealth program. The contract, valued up to $171,000 CAD in the first year, aims to onboard 100 patients per month into a three-month monitoring program. This marks the seventh contract signed by Cloud DX in 2023, highlighting its ongoing expansion in the healthcare sector. The Connected Health™ platform promises improved care outcomes and reduced hospital readmission rates, leveraging peer-reviewed studies to support its efficacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
Rhea-AI Summary

Cloud DX has launched its first Remote Patient Monitoring (RPM) program for Type 2 Diabetes patients in partnership with a leading Ontario health organization. The program aims to enroll 100 patients, potentially generating $48,000 CAD annually in recurring revenue. Utilizing the Connected Health™ platform, it will streamline diabetes management, providing real-time monitoring of blood sugar levels and automated alerts for patients and healthcare providers. This initiative aligns with the American Diabetes Association's encouragement of virtual care and aims to enhance patient outcomes through better disease management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.35%
Tags
none
Rhea-AI Summary

Cloud DX has secured its 8th contract with a community paramedic group in Ontario to implement a Remote Patient Monitoring (RPM) program for seniors, funded through the provincial government's Community Paramedicine for Long-Term Care (CPLTC) initiative. The contract, valued at up to $110,000 CAD, includes 75 Connected Health™ kits and will continue through March 2024. Feedback indicates that RPM can reduce hospital readmissions. Cloud DX has experienced remarkable growth, with a 233% year-over-year increase in contracts, including 5 new partnerships in 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none

FAQ

What is the current stock price of Cloud Dx (CDXFF)?

The current stock price of Cloud Dx (CDXFF) is $0.084 as of February 7, 2025.